You searched for "studies"
Vabysmo receives NICE approval
The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...SCOPE Announces 2025 Independent Prescriber Bursary Award Winners
SCOPE is proud to announce the winners of its 2025 Independent Prescriber (IP) Bursary Awards, an initiative now in its fourth year. Designed to support optometrists in gaining IP qualifications by covering course fees, the awards continue to attract strong...The Worshipful Company of Spectacle Makers awards two Master’s Medals for early career research
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of two Master’s Medals for 2025. Fabian Yii from Edinburgh was awarded the Master’s Medal for his paper, 'Fundus Refraction Offset as a Personalized Biomarker for 12-Year Risk...
Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report
Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...Everyday diabetes medicine could treat common cause of blindness
Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...
Comparison of the efficacy of anti-VEGFs agents in nvAMD
This retrospective multicentric study conducted in Israel and Canada, compared the efficacy of bevacizumab, aflibercept 2mg and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). Included were treatment-naïve nvAMD eyes receiving ≥12 months of treat-and-extend (T&E) anti-VEGF therapy...RANZCO Congress 2025
The Royal Australian and New Zealand College of Ophthalmologists Annual Congress 2025UK Paediatric Glaucoma Society Annual Meeting 2025
by Hussain Aluzri, Junior Glaucoma Cinical Research Fellow, Birmingham Midland Eye Centre, UK. The UKPGS 2025 conference was another resounding success, held on 24 January 2025 at the Cavendish Conference Centre, London. The event commenced with an opening address by...
Elevated anxiety levels in central serous chorioretinopathy
This prospective cross-sectional case-control, questionnaire-based study was aimed to compare association of anxiety disorder in patients with central serous chorioretinopathy (CSCR) and age-gender-matched healthy controls. Participants in the age group of 18–55 years were divided into 2 groups. Group A...Urban Changes and Rural Struggles for Ophthalmology in China
China is by far the most populated country in the world, with over 1.3 billion inhabitants. It is also the country with the highest number of blind and visually impaired people. As a developing country, half of China’s population lives...
Thyroid recession drift
The authors investigated patients with thyroid ophthalmopathy (TO) who underwent unilateral inferior rectus recession for hypotropia with or without adjustable sutures to determine extent of postoperative surgical alignment. Group A comprised 13 TO patients with inferior rectus recession with adjustable...
